The novel treatment of the medication represents a major development in the handling of the condition. Unlike existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and glucose-dependent https://tirzepatide-peptide586489.dsiblogger.com/75139094/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment